Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Metlife (MET) EBITDA Margin (2016 - 2025)

Metlife (MET) has 17 years of EBITDA Margin data on record, last reported at 30.29% in Q3 2025.

  • For Q3 2025, EBITDA Margin rose 405.0% year-over-year to 30.29%; the TTM value through Sep 2025 reached 41.5%, up 2410.0%, while the annual FY2024 figure was 0.48%, 3287.0% down from the prior year.
  • EBITDA Margin reached 30.29% in Q3 2025 per MET's latest filing, up from 10.41% in the prior quarter.
  • Across five years, EBITDA Margin topped out at 291.77% in Q4 2022 and bottomed at 99.06% in Q2 2022.
  • Average EBITDA Margin over 5 years is 9.76%, with a median of 3.45% recorded in 2024.
  • Peak YoY movement for EBITDA Margin: soared 29171bps in 2022, then crashed -25367bps in 2023.
  • A 5-year view of EBITDA Margin shows it stood at 0.06% in 2021, then skyrocketed by 477486bps to 291.77% in 2022, then tumbled by -87bps to 38.1% in 2023, then crashed by -221bps to 46.01% in 2024, then soared by 166bps to 30.29% in 2025.
  • Per Business Quant database, its latest 3 readings for EBITDA Margin were 30.29% in Q3 2025, 10.41% in Q2 2025, and 25.22% in Q1 2025.